机构:[1]Department of Critical Medicine, Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People’s Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China深圳市康宁医院深圳市人民医院深圳医学信息中心[2]Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People’s Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China深圳市康宁医院深圳市人民医院深圳医学信息中心[3]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[4]Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan 523125, Guangdong, China[5]State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China[6]National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China
Scientific and technological innovation project of China Academy of Chinese Medical Sciences (CI2023D003, CI2021B014); the Innovation Team and Talents
Cultivation Program of National Administration of Traditional Chinese
Medicine (No: ZYYCXTD-C-202002); the CACMS Innovation Fund
(CI2023E002, CI2021A05101 and CI2021A05104); the Science and
Technology Foundation of Shenzhen (JCYJ20210324115800001); the
Science and Technology Foundation of Shenzhen (Shenzhen Clinical
Medical Research Center for Geriatric Diseases); the Shenzhen Medical
Research Fund (B2302051); the Distinguished Expert Project of Sichuan
Province Tianfu Scholar (CW202002); the study was supported by the
Shenzhen Key Laboratory of Prevention and Treatment of Severe Infections (Grant No. ZDSYS20200811142804014); the Shenzhen Science
and Technology Innovation Committee (SZSTI)
(RCYX20221008092950121); the National Natural Science Foundation
of China (82070517); the Major scientific research project of Shenzhen
People’s Hospital (SYWGSJCYJ202202); the Natural Science Foundation of Shenzhen for basic research (JCYJ20230807111911024 and
JCYJ20230807111959039), and China Postdoctoral Science Foundation (2023M741600).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|1 区环境科学与生态学
小类|1 区环境科学
最新[2025]版:
大类|1 区环境科学与生态学
小类|1 区环境科学
第一作者:
第一作者机构:[1]Department of Critical Medicine, Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People’s Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Critical Medicine, Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People’s Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China[3]State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[4]Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan 523125, Guangdong, China[5]State Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China
推荐引用方式(GB/T 7714):
Li Guanjun,Liu Xueyan,Sun Xin,et al.Polystyrene microplastics induce anxiety via HRAS derived PERK-NF-κB pathway[J].Environment International.2024,185:108543.doi:10.1016/j.envint.2024.108543.
APA:
Li Guanjun,Liu Xueyan,Sun Xin,Huang Ling,Kuang Wenhua...&Wang Jigang.(2024).Polystyrene microplastics induce anxiety via HRAS derived PERK-NF-κB pathway.Environment International,185,
MLA:
Li Guanjun,et al."Polystyrene microplastics induce anxiety via HRAS derived PERK-NF-κB pathway".Environment International 185.(2024):108543